GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indoco Remedies Ltd (BOM:532612) » Definitions » Cash Flow for Lease Financing

Indoco Remedies (BOM:532612) Cash Flow for Lease Financing : ₹0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Indoco Remedies Cash Flow for Lease Financing?

Indoco Remedies's Cash Flow for Lease Financing for the three months ended in Dec. 2023 was ₹0 Mil. Indoco Remedies's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0 Mil.

Compared with last quarter (₹0 Mil in Sep. 2023 ), Indoco Remedies's Cash Flow for Lease Financing remained the same in Dec. 2023 (₹0 Mil).

Indoco Remedies Cash Flow for Lease Financing Historical Data

The historical data trend for Indoco Remedies's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indoco Remedies Cash Flow for Lease Financing Chart

Indoco Remedies Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.75 -7.94 -12.80 -17.70

Indoco Remedies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Indoco Remedies Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indoco Remedies Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Indoco Remedies's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Indoco Remedies (BOM:532612) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indoco Remedies Ltd (BOM:532612) » Definitions » Cash Flow for Lease Financing
Comparable Companies
BOM:530549 BOM:506690 BOM:532300 BOM:509079 BOM:524735 BOM:512529 BOM:524164 BOM:524372 NSE:RPGLIFE BOM:543748 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
INDOCO:India
Address
166 CST Road, Indoco House, Kalina, Santacruz (East), Mumbai, MH, IND, 400 098
Website
https://www.indoco.com
Indoco Remedies Ltd is an India based pharmaceutical company. It is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). Its manufacturing products for different therapeutic segments including respiratory, stomatology, women's health, nutritional products, gastroenterology, cardiology, metabolic disorders, and primary care medicines. Geographically, it generates the majority of the revenue from India.

Indoco Remedies (BOM:532612) Headlines

No Headlines